Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
- 3 March 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 3 (3), 253-271
- https://doi.org/10.1517/13543784.3.3.253
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5′-triphosphates of various anti-HIV nucleoside analogsAntiviral Research, 1993
- Inhibition of HIV infection by flavanoidsAntiviral Research, 1993
- Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitorsAntiviral Research, 1993
- Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitroNature, 1993
- HIV and multidrug resistanceNature, 1993
- HIV-1 error revealedNature, 1993
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templatesAntiviral Research, 1991
- Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferonAntiviral Research, 1991
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989